- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03694054
Care Coordination in Oncology, Quality Among Patients With Lung Cancer and Their Caregivers
Exploratory Evaluation of Family Caregiver Application (FCA) on Quality Among Persons With Lung Cancer and Their Family Caregivers
Studieoversikt
Detaljert beskrivelse
The case-matched controlled design, exploratory evaluation study will look at how exposure to a care coordination tool impacts quality and performance indicators associated with oncology care from the perspective of patients, caregivers, and providers.
Geisinger research staff will recruit lung cancer patients and their caregivers across three Geisinger locations: Geisinger Medical Center (GMC), Geisinger Wyoming Valley Medical Center (GWV) and Geisinger Community Medical Center (GCMC). GMC will serve as the intervention site and GWV and GCMC as control sites.
Eligible participants will be identified by the study staff through the electronic health record as well as through clinical staff and approached in the oncology clinic as part of a schedule office visit and/or treatment. For the purpose of study awareness, informational flyers will be available to patients in the exam rooms, waiting rooms, and through Oncology Care's Multi-Disciplinary clinic. Participants will asked to identify a caregiver who will participate in the study as well, however this is not required.
Case dyads enrolled at the intervention site (GMC) will be asked to complete a survey when they join the study and at the end of the study. Participants will also be asked to enroll in the care coordination tool, a health information solution that integrates the patient, caregiver, and clinical data to enhance communication and improve quality of care and performance outcomes. Patients will also be asked to give permission to the study team to access their health information via the e electronic health record. Participants will be in the research study for about 8-10 weeks.
Control dyads enrolled at the control site (GWV and GCMC) will be asked to complete a survey eight weeks after consenting to participate. Patients will be asked to give permission to the study team to access their health information via the electronic health record. Participants will be in the research study for about 8-10 weeks.
The study will also enroll oncology care providers within the Medical Oncology or Radiation Oncology departments at GMC and who have patients enrolled in the study. Providers will be asked to participate in a 30-minute interview to get their feedback and insights on the care coordination tool.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Pennsylvania
-
Danville, Pennsylvania, Forente stater, 17822
- Geisinger Health System
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
Patients:
- Patients who are 18 years of age or older and diagnosed with lung cancer who 1) are scheduled to start Oncology Care (chemo and/or radiation-therapies) OR 2) on active Oncology Care and recently started within 3 weeks (<27 days for experimental arm; <56 days control arm)
- Receive care at GMC, GWV, or GCMC
- English-speaking
- Established/intends to establish a MyGeisinger Account (cases only)
Caregivers:
- Recognized/intends to be recognized as proxy for patient's MyGeisinger Account (cases only)
- English-speaking
Providers:
- Any health care provider within Medical Oncology or Radiation Oncology at GMC, where care coordination tool is standard of care, who has a patient enrolled.
Exclusion Criteria:
Patients:
- Patients who are not diagnosed with lung cancer.
- Patients who are diagnosed with lung cancer and are on active Oncology Care exceeding 3 weeks (>27 days experimental arm; >56 days control arm).
Providers:
- Any healthcare provider not within the Medical Oncology or Radiation Oncology departments.
- Any healthcare provider within Medical Oncology or Radiation Oncology who does not have a patient enrolled (Case Dyad).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Care coordination patients, caregivers
Patients and caregivers enroll in using care coordination tool during oncology care and treatment.
|
Participants will be asked to enroll in the care coordination tool, a health information technology solution that integrates cross-sector data to enhance communication and improve quality of care and performance outcomes.
Patients will also be asked to provide consent to allow the study team to access additional health information via the electronic health record.
|
Ingen inngripen: Standard of care patients, caregivers
Patients and caregivers receive oncology care and treatment.
|
|
Eksperimentell: Oncology Care Providers
Oncology care providers with patients enrolled in care coordination tool.
|
Participants will be asked to enroll in the care coordination tool, a health information technology solution that integrates cross-sector data to enhance communication and improve quality of care and performance outcomes.
Patients will also be asked to provide consent to allow the study team to access additional health information via the electronic health record.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Patient Satisfaction
Tidsramme: 8 weeks
|
To evaluate the difference in patient satisfaction associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control patient analyses will also be performed to detect role-level differences in perceptions of satisfaction associated with FCA exposure.To evaluate the association of the change in patient satisfaction associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in satisfaction perceptions based on role.
|
8 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Caregiver Satisfaction
Tidsramme: 8 weeks
|
To evaluate the difference in caregiver satisfaction associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control caregiver analyses will also be performed to detect role-level differences in perceptions of satisfaction associated with FCA exposure.
To evaluate the association of the change in caregiver satisfaction associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in satisfaction perceptions based on role.
|
8 weeks
|
Patient Quality of Life
Tidsramme: 8 weeks
|
To evaluate the difference in patient quality of life associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control patient analyses will also be performed to detect role-level differences in perceptions of quality of life associated with FCA exposure.To evaluate the association of the change in patient quality of life associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in quality of life perceptions based on role.
|
8 weeks
|
Caregiver Quality of Life
Tidsramme: 8 weeks
|
To evaluate the difference in caregiver quality of life associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control caregiver analyses will also be performed to detect role-level differences in perceptions of quality of life associated with FCA exposure.
To evaluate the association of the change in caregiver quality of life associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in quality of life perceptions based on role.
|
8 weeks
|
Family Centered Care
Tidsramme: 8 weeks
|
To evaluate the difference in family centered care associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control patient and caregiver analyses will also be performed to detect role-level differences in perceptions of family centered care associated with FCA exposure.
To evaluate the association of the change in family centered care associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in family centered care perceptions based on role.
|
8 weeks
|
Patient Experience
Tidsramme: 8 weeks
|
To evaluate the difference in patient experience associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control patient analyses will also be performed to detect role-level differences in perceptions of experience associated with FCA exposure.To evaluate the association of the change in patient experience associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in experience perceptions based on role.
|
8 weeks
|
Caregiver Burden
Tidsramme: 8 weeks
|
To evaluate the difference in caregiver burden associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control caregiver analyses will also be performed to detect role-level differences in perceptions of burden associated with FCA exposure.To evaluate the association of the change in caregiver burden associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
To evaluate the association of the change in caregiver burden associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
|
8 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Lisa Bailey-Davis, DEd, RD, Geisinger Clinic
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2018-0172
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Lungekreft
-
Yonsei UniversityFullført
-
Novartis PharmaceuticalsFullførtNevroendokrine svulster | Avansert NET av GI Origin | Advanced NET of Lung OriginForente stater, Colombia, Italia, Taiwan, Storbritannia, Belgia, Tsjekkia, Tyskland, Japan, Saudi-Arabia, Canada, Nederland, Spania, Korea, Republikken, Libanon, Østerrike, Kina, Hellas, Sør-Afrika, Thailand, Ungarn, Tyrkia, Polen, Slov... og mer
-
The Cleveland ClinicTilbaketrukketOne Lung Ventillation (OLV) | To lungeventilasjon (TLV) | Positivt End Expiratory Pressure (PEEP) | Null sluttekspirasjonstrykk (ZEEP)
-
Assiut UniversityHar ikke rekruttert ennåLungekreft | Lungeskade | Bleb Lung
-
RenJi HospitalRekrutteringMultiple Synchronous Lung Cancers (MSLC)Kina
-
Poitiers University HospitalFullførtEndobronchial Transbronchial Needle Aspiration Lung Cancer Procore
-
University of LorraineFullførtBare barn | Spontan pneumothorax | Idiopatisk pneumotoraks | Bleb LungFrankrike
-
AHS Cancer Control AlbertaCross Cancer InstituteFullførtOmfattende Stage Small Cel Lung CancerCanada
-
Damascus UniversityUniversity Children's HospitalFullførtEsophageal atresi | One Lung Ventilation OLV | Hydrocystoma | Pneumonektomi | Pleura; AbscessDen syriske arabiske republikk
-
Ministry of Health, Saudi ArabiaHar ikke rekruttert ennåLuftveissykdom | Prematuritet | Ventilator Lung; Nyfødt
Kliniske studier på Care coordination tool
-
Lawson Health Research InstituteUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Canadian... og andre samarbeidspartnereFullførtDepresjon | Hjertefeil | Slag | Hypertensjon | Hjerte-og karsykdommer | Diabetes | Magesår | Kreft | Leddgikt | Leddgikt | Muskel- og skjelettsmerter | Astma | Gastroøsofageal refluks | Demens | Angst | HIV | Crohns sykdom | Osteoporose | Ulcerøs kolitt | Kronisk obstruktiv lungesykdom (KOLS) | Høyt kolesterol | Alzheimers sykdom | Kronisk bronkitt og andre forholdCanada
-
Lisa TuchmanHealth Resources and Services Administration (HRSA)FullførtOmsorgskoordinering | Overgang til helsevesenet
-
Northwestern UniversityNorthwestern Memorial HospitalFullførtGjeninnleggelse av pasientForente stater
-
Thomas Jefferson UniversityFullførtHematopoetisk og lymfoid celle-neoplasma | Ondartet fast neoplasmaForente stater
-
University of WolverhamptonThe Royal Wolverhampton Hospitals NHS TrustRekrutteringAvansert prostatakarsinomStorbritannia
-
National Eye Institute (NEI)RekrutteringCone-Rod Degenerasjon | Rod-Cone DegenerasjonForente stater, Australia
-
Herlev HospitalFullført
-
University of WashingtonRekruttering
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM); Partners in HealthFullførtInfeksjon på operasjonsstedetRwanda
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR); MOUNT SINAI HOSPITAL; Trillium...RekrutteringEldre voksne med komplekse omsorgsbehovCanada